Showing results (111-120 of 1,553) with videos related to
Sort By:
Pageof 156
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2004
Prions can infect primary cultured neurons and astrocytes and promote neuronal cell deathSabrina Cronier, Hubert Laude, Jean-Michel PeyrinPhysics in Medicine and Biology|September 26, 2022
Iterative tomographic reconstruction with TV prior for low-dose CBCT dental imagingLouise Friot-Giroux, Françoise Peyrin, Voichita MaximThe American Journal of Clinical Nutrition|November 13, 2015
Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic reviewLaurent Peyrin-Biroulet, Nicolas Williet, Patrice CacoubNature Reviews. Gastroenterology & Hepatology|August 19, 2015
Biologic agents for IBD: practical insightsSilvio Danese, Lucine Vuitton, Laurent Peyrin-BirouletCurrent Drug Targets|June 10, 2016
Evolving Treatment Algorithms in Crohn's DiseaseAndrew Wisniewski, Silvio Danese, Laurent Peyrin-BirouletCurrent Drug Targets|March 10, 2010
Efficacy of TNF antagonists beyond one year in adult and pediatric inflammatory bowel diseases: a systematic reviewAbderrahim Oussalah, Silvio Danese, Laurent Peyrin-BirouletJournal of Clinical Medicine|July 29, 2020
Adaptive Designs: Lessons for Inflammatory Bowel Disease TrialsFerdinando D'Amico, Silvio Danese, Laurent Peyrin-BirouletDigestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 18, 2019
The management of emergency hospital visits for inflammatory bowel diseases: A French national expert consensus reportXavier Hébuterne, Laurent Peyrin-Biroulet, Pierre HausfaterArchives Internationales De Physiologie Et De Biochimie|August 1, 1980
[Relation between dopamine and serotonin motor effects on isolated rat duodenum. Possible participation of an excitatory dopaminergic receptor]S Miachon, L Peyrin, J F CierExpert Opinion on Drug Discovery|June 27, 2025
The preclinical discovery and development of upadacitinib for the treatment of Crohn's diseaseSophie Vieujean, Silvio Danese, Laurent Peyrin-BirouletPageof 156